BLFS241220C12500
- 0.00
- 0.000.00%
BioLife Solutions Newsroom
Maxim Group Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
Biolife Solutions Insider Sold Shares Worth $882,110, According to a Recent SEC Filing
H.C. Wainwright Maintains BioLife Solutions(BLFS.US) With Buy Rating, Cuts Target Price to $27
BioLife Solutions Is Maintained at Buy by HC Wainwright & Co.
Analyst Expectations For BioLife Solns's Future
BioLife Solutions: Strategic Refocus and Strong Q3 Performance Bolster Buy Rating With $27 Price Target
Express News | BioLife Solutions, Inc. : H.c. Wainwright Cuts Target Price to $27 From $29
BioLife Solutions (BLFS) Makes Promising Strategic Pivot
Earnings Update: BioLife Solutions, Inc. (NASDAQ:BLFS) Just Reported And Analysts Are Trimming Their Forecasts
BioLife Solutions Completes Strategic Move Away From Capital Equipment Businesses >BLFS
Press Release: BioLife Solutions Announces $6.1 Million Sale of Its Custom Biogenic Systems Freezer Subsidiary
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $28 to $32
BioLife Solutions Is Maintained at Buy by Craig-Hallum
BioLife Solns Analyst Ratings
Express News | BioLife Solutions Inc : Jefferies Raises Target Price to $30 From $26
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $31
BioLife Solutions: Strategic Refocus and Strong Financial Performance Justify Buy Rating
BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Tops Revenue Estimates
BioLife Solutions Lowers FY24 Revenue View to $98.0M-$100.0M From $99.0M-$101.0M
BioLife Solutions Reports Q3 ContOps GAAP EPS (4c), Consensus (9c)